Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating Multiple Myeloma Cells
continue →
Topics:
CELLSEARCH,
Liquid biopsy,
Multiple myeloma,
Dana-Farber Cancer Institute,
Multiple Myeloma Research Foundation
As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where its CELLSEARCH® technology can enumerate Circulating Multiple Myeloma Cells (CMMCs) for non-invasive monitoring of disease
continue →
Topics:
CELLSEARCH,
Liquid biopsy,
Multiple myeloma,
CLIA Lab,
LDT
CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood
continue →
Topics:
CTCs,
CELLSEARCH,
Liquid biopsy,
Blood Enrichment,
CellMag
Developments for CELLSEARCH and DEPArray Technologies to be Featured at the Molecular Medicine Tri-Conference
continue →
Topics:
Liquid biopsy,
Precision Medicine,
Circulating tumor cells,
rare cells
Northwestern University researchers use gold standard liquid-biopsy technology to deepen understanding of metastatic breast cancer
continue →
Topics:
Liquid biopsy,
Precision Medicine,
Circulating tumor cells,
metastatic breast cancer,
rare cells
Automated volume reduction instrument increases precision and accuracy in rare cell workflows
continue →
Topics:
Liquid biopsy,
Precision Medicine,
rare cells,
volume reduction,
VRNxT
World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer
continue →
Topics:
CTCs,
Liquid biopsy,
Precision Medicine,
rare cells
Liquid biopsy data reveals “intriguing” association between ESR1 mutations, HER2 alterations and prognosis
continue →
Topics:
CELLSEARCH,
Liquid biopsy,
Precision Medicine,
metastatic breast cancer
Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker
continue →
Topics:
deparray,
CELLSEARCH,
Liquid biopsy,
Precision Medicine,
metastatic breast cancer,
lynphoma,
CTC cluster,
melanoma
Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression
continue →
Topics:
FFPE,
deparray,
CELLSEARCH,
Liquid biopsy,
Precision Medicine,
Multiple myeloma,
CMMCs